GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » Institutional Ownership

PT Merck Tbk (PT Merck Tbk) Institutional Ownership : 1.24% (As of Jun. 16, 2024)


View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PT Merck Tbk's institutional ownership is 1.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PT Merck Tbk's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PT Merck Tbk's Float Percentage Of Total Shares Outstanding is 0.00%.


PT Merck Tbk Institutional Ownership Historical Data

The historical data trend for PT Merck Tbk's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Institutional Ownership Chart

PT Merck Tbk Historical Data

The historical data trend for PT Merck Tbk can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.01 0.72 0.72 0.72 1.77 1.77 1.24 1.24 1.24 1.24

PT Merck Tbk Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


PT Merck Tbk (PT Merck Tbk) Business Description

Traded in Other Exchanges
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk (PT Merck Tbk) Headlines

No Headlines